...
首页> 外文期刊>Transactions of the Royal Society of Tropical Medicine and Hygiene >No benefits from combining chloroquine with artesunate for three days for treatment of Plasmodium falciparum in Guinea-Bissau.
【24h】

No benefits from combining chloroquine with artesunate for three days for treatment of Plasmodium falciparum in Guinea-Bissau.

机译:在几内亚比绍治疗三天后,将氯喹与青蒿琥酯联合使用治疗恶性疟原虫没有任何好处。

获取原文
获取原文并翻译 | 示例
           

摘要

The use of a combination of chloroquine and artesunate has been suggested for treatment of malaria in Africa. We used concomitant as well as sequential medication with these 2 drugs in relation to each drug separately for children infected with Plasmodium falciparum in Guinea-Bissau from March 2000 to November 2001. By block-randomization, 474 children with symptomatic malaria were divided into 4 groups and given either a total of 8 mg artesunate per kg bodyweight for 3 d, a total of 25 mg chloroquine base per kg bodyweight for 3 d, both drugs concomitantly for 3 d, or both drugs in sequence. All children were followed weekly for 5 weeks. On day 28, parasites had been detected in 40% of the children who were treated with artesunate only compared with 21% treated with chloroquine, 20% treated with artesunate in combination with chloroquine, and 16% treated with artesunate and chloroquine in sequence; on day 35 the corresponding percentages were 48%, 29%, 27%, and 24%, respectively. The outcome of the combination of chloroquine and artesunate in the doses studied was similar to the outcome of chloroquine monotherapy regardless of whether the 2 drugs are given concomitantly (relative risk [RR] = 0.93, 95% CI 0.56-1.53, P = 0.76) or in sequence (RR = 0.78, 95% CI 0.47-1.28, P = 0.32). Thus, neither an antagonistic, an additive, or a synergistic effect of the 2 drugs was indicated.
机译:在非洲,已建议使用氯喹和青蒿琥酯的组合治疗疟疾。我们对2000年3月至2001年11月在几内亚比绍感染恶性疟原虫的儿童分别使用了这2种药物的同时用药和顺序用药。通过分组随机分组,将474例有症状疟疾的儿童分为4组并分别给予每公斤体重8毫克青蒿琥酯3天,每公斤体重总计25毫克氯喹碱3天,两种药物同时治疗3天或两种药物依次给药。所有儿童每周接受随访,持续5周。在第28天,按顺序使用青蒿琥酯治疗的儿童中有40%检出了寄生虫,相比之下,用氯喹治疗的儿童为21%,用青蒿琥酯与氯喹组合治疗的儿童为20%,用青蒿琥酯和氯喹治疗的儿童为16%;在第35天,相应的百分比分别为48%,29%,27%和24%。无论是否同时给予2种药物,氯喹和青蒿琥酯联合使用的剂量与氯喹单药治疗的结果相似(相对危险度[RR] = 0.93,95%CI 0.56-1.53​​,P = 0.76)或依序排列(RR = 0.78,95%CI 0.47-1.28,P = 0.32)。因此,两种药物均未显示出拮抗作用,加和作用或协同作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号